article thumbnail

Rice University’s ROGUE device implants a ‘living pharmacy’ to combat diabetes and obesity

Express Pharma

Diabetes has emerged as a significant health challenge in India, affecting millions across both urban and rural areas. According to the National Family Health Survey (NFHS-5) 2019-21, the prevalence of diabetes among adults aged 15 years and above is substantial, with urban areas reporting higher rates compared to rural regions.

article thumbnail

STAT+: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver

STAT

Food and Drug Administration added Eli Lilly’s Mounjaro to its list of drugs facing shortages, highlighting the company’s struggles to meet booming demand for the newly approved diabetes injection , STAT notes.

Diabetes 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Escalating Dosages of Levothyroxine – Why?

Med Ed 101

I am going to outline a common case of escalating dosages of levothyroxine. KE is a 68-year-old female with a history of GERD, anemia, osteoarthritis, hypertension, and diabetes. The post Escalating Dosages of Levothyroxine – Why? Her current medication list includes: Metformin 500 mg TID Ferrous sulfate […].

Dosage 40
article thumbnail

Key senators make a big pivot on bipartisan insulin cost proposal

STAT

The new legislation by Senate Diabetes Caucus co-chairs Sens. WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. Jeanne Shaheen (D-N.H.)

Dosage 246
article thumbnail

Researchers from Queen’s University Belfast develop 3D printed bandage to treat diabetic foot ulcers

Express Pharma

Queen’s University Belfast has designed a new 3D printed bandage which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs). These scaffolds can release both a bulk and sustained release of antibiotic loaded molecules to treat diabetic ulcers.

article thumbnail

STAT+: Pharmalittle: We’re reading about a Merck deal, weight loss drugs, and lots more

STAT

Nearly one-third halted treatment within four weeks, before recommended dosages reached the targeted strength. GLP-1 drugs are transforming the treatment of diabetes and obesity, but many Black Americans, including patients and medical experts, worry that their community is being left behind , STAT explains.  Black

Diabetes 266
article thumbnail

Recent Biosimilar Approvals By the FDA

Big Molecule Watch

Approval of Accord’s Trastuzumab Biosimilar : On September 18, 2024, Accord announced that the Food and Drug Administration (FDA) approved a 420 mg dosage of HERCESSI (trastuzumab-strf), a biosimilar to Genentech’s HERCEPTIN (trastuzumab), to treat HER2-overexpressing breast and gastric or gastroesophageal junction adenocarcinoma.